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Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic
disorder characterized by features reminiscent of marked pre-
mature ageing1,2. Here, we present evidence of mutations in
lamin A (LMNA) as the cause of this disorder. The HGPS gene
was initially localized to chromosome 1q by observing two cases
of uniparental isodisomy of 1q—the inheritance of both copies of
this material from one parent—and one case with a 6-megabase
paternal interstitial deletion. Sequencing of LMNA, located in
this interval and previously implicated in several other heritable
disorders3,4, revealed that 18 out of 20 classical cases of HGPS
harboured an identical de novo (that is, newly arisen and not
inherited) single-base substitution, G608G(GGC > GGT), within
exon 11. One additional case was identified with a different
substitution within the same codon. Both of these mutations
result in activation of a cryptic splice site within exon 11,
resulting in production of a protein product that deletes 50
amino acids near the carboxy terminus. Immunofluorescence
of HGPS fibroblasts with antibodies directed against lamin A
revealed that many cells show visible abnormalities of the nuclear
membrane. The discovery of the molecular basis of this disease
may shed light on the general phenomenon of human ageing.
Premature senescence is the hallmark of HGPS (Online Mende-
lian Inheritance in Man (OMIM) 176670), both clinically and in cell
culture1,2. Children affected with HGPS typically appear normal at
birth, but within a year the characteristic features of failure to thrive,
delayed dentition, alopecia and sclerodermatous skin changes begin
to appear. Death occurs on average at age 13, and at least 90% of the
patients die from progressive atherosclerosis of the coronary and
cerebrovascular arteries2. Although the prevailing hypothesis of the
inheritance of HGPS has been sporadic autosomal dominant5,6, the
possibility of autosomal recessive inheritance7,8 led us to conduct a
genome-wide scan searching for evidence of homozygosity9. A
whole-genome scan including 403 polymorphic microsatellite
markers with an average spacing of 9.2 cM was performed on 12
DNA samples derived from individuals considered by one of us
(W.T.B.) to represent classical HGPS. Although no evidence of
homozygosity was identified in the overall sample set, two HGPS
samples were found to have uniparental isodisomy (UPD) of
chromosome 1q (Fig. 1a). Spectral karyotyping and G-banding of
one of the two UPD cases showed a normal karyotype (data not
shown).
An earlier report10 described an abnormal karyotype in a mono-
zygotic twin with HGPS. That report described a mosaic cell
population in which 70% of the cells contained a balanced inverted
insertion (46,XY, inv ins (1;1)(q32;q44q23)), whereas the rest of the
cells had an apparently normal karyotype. We obtained a fibroblast
culture from the same individual (sample identification C8803), as
well as his parents. Unexpectedly, genotyping of microsatellite
markers identified a roughly 6-megabase (Mb) interval where all
tested paternal alleles were completely missing (Fig. 1b). We
confirmed that this deletion was also present in the cells that had
an apparently normal karyotype, using fluorescent in situ hybrid-
ization (FISH) with bacterial artificial chromosomes (BACs) that
map throughout this interval (Fig. 1c). Putting all of this infor-
mation together with genotypes from a total of 44 additional
microsatellite markers, we determined that the HGPS gene must
lie in an interval of 4.82 Mb on proximal chromosome 1q (Fig. 1d).
The candidate interval contains roughly 80 known genes. Our
attention was immediately drawn to one of them, the LMNA gene
that encodes two protein products (lamin A and lamin C), repre-
senting major constituents of the inner nuclear membrane lamina.
Mutations in LMNA have been found to be the cause of six different
recessive and dominant disorders, including Emery–Dreifuss
muscular dystrophy type 2, a form of dilated cardiomyopathy, the
Dunnigan type of familial partial lipodystrophy, limb girdle mus-
cular dystrophy type 1B, Charcot–Marie–Tooth disorder type 2B1,
and mandibuloacral dysplasia (see reviews of laminopathies in refs
3, 4). The gene contains 12 exons and covers about 25 kilobases of
genomic DNA. Lamin A is coded by exons 1–12 and lamin C by
exons 1–10. A splice site within exon 10, located just upstream of the
stop codon for lamin C, splices together with exons 11 and 12 to
code for lamin A11,12.
Polymerase chain reaction (PCR) amplification of all of the exons
of the LMNA gene (including exon–intron boundaries), followed by
direct sequencing, was carried out in 23 samples from patients with
classical HGPS. In 18 of these samples a heterozygous base substi-
tution (G608G(GGC . GGT)) within exon 11 of the LMNA gene
was identified (Fig. 2a). In HGPS sample AG10801, a different
heterozygous base substitution was identified within the same
codon (G608S(GGC . AGC)) (Fig. 2a). In HGPS sample
AG10677, we identified a heterozygous base substitution within
exon 2 (E145K(GAG . AAG)). In the eight cases where DNA from
both parents was available, the G608G mutation was absent in the
parents, confirming that these are de novo mutations. Similarly, the
G608S and E145K mutations were not found in parents of AG10801
or AG10677, respectively. Thus, of the 23 classical HGPS cases
studied, there were only three in which no LMNA mutations were
found (Table 1): the two UPD cases (AG10578 and HGADFN005)
and the sample with the 6-Mb paternal deletion (C8803).
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The de novo recurrence of the same exact point mutation in 18
out of 20 cases of classical HGPS is a surprising finding, but is not
without precedent. The common HGPS mutation is a C to T in the
context of a CpG dinucleotide, which represents the most mutable
base in the vertebrate genome, as a methylated C can be deaminated
to T and miscopied. In the E145K case and in four out of four
G608G HGPS cases where parental DNA was available and silent
polymorphisms in exon 10 (H566H) or exon 7 (D446D) were
informative, we were able to determine that the new mutation was
paternal in origin (data not shown). A very similar phenomenon
occurs in achondroplasia13, where nearly all sporadic cases are due
to paternal CpG to TpG mutations in the FGFR3 gene, resulting in
an apparent gain-of-function mutation.
The most common mutation, G608G(GGC . GGT), is a
silent substitution. The second mutation in the same codon,
G608S(GGC . AGC), results in a conservative substitution of
serine for glycine. How is it possible that these bland-appearing
de novo mutations could cause HGPS? Inspection of the normal
sequence surrounding codon 608 reveals that both of the observed
HGPS mutations improve the match to a consensus splice donor
(Fig. 2b), suggesting that they might activate a cryptic splice site. To
test this hypothesis, PCR with reverse transcription (RT) was
performed using a forward primer spanning the junction of exons
7 and 8, and a reverse primer in exon 12. In RNA from unaffected
individuals, the expected product appears (Fig. 2c). In RNA samples
from cell lines harbouring HGPS mutations, an additional smaller
RT–PCR product appears. Sequence of these fragments shows that
150 nucleotides within exon 11 are missing. As the reading frame is
maintained, this abnormal transcript would be expected to code for
a protein with an internal deletion of 50 amino acids near the C
Figure 1 Localization of the HGPS gene to a 4.82-Mb interval on chromosome 1q.
a, Uniparental isodisomy of chromosome 1q in fibroblasts from two patients with HGPS
(filled symbols). A subset of markers and their genotypes are shown. NA, not available.
b, The boxed interval is the region in proband C8803 that has been inherited exclusively
from the mother. c, FISH analysis of a metaphase spread from C8803 fibroblasts,
hybridized with BAC probes RP11-110J1 (green) and RP11-91G5 (red). d, Summary map
of the candidate region. Microsatellite markers are indicated with arrows; horizontal bars
indicate BAC probes that were used for FISH on sample C8803. LMNA is one of the
approximately 80 known genes in the 4.82-Mb candidate interval.
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terminus of lamin A. Lamin C would be unaffected. Cloning and
sequencing of the normal full-length fragment obtained from
RT–PCR on RNA extracted from primary fibroblasts containing
the more common codon 608 mutation revealed that 7 out of 23
clones carry the mutant sequence. Thus, activation of the cryptic
splice site within exon 11 is not complete. To determine whether the
mutant messenger RNA is actually translated into protein, a western
blot was performed using a monoclonal antibody against lamin A/C
(Fig. 2d). In addition to the normal bands for lamin A and lamin C,
an additional band is present in four of the lanes corresponding to
samples from classical HGPS cases, but not in their parents. The
abnormal band is not visible in the lane that contains the protein
sample from classical HGPS patient AG11498 (which carries
G608G(GGC . GGT)), but this is probably due to the very small
amount of lamin A being expressed in this particular fibroblast line.
Although the major cause of HGPS appears to be the creation of
an abnormal splice donor in exon 11, the finding of a de novo point
mutation in exon 2 in a single patient (AG10677) is of interest. In
retrospect, this patient14 had atypical clinical features (including
persistence of coarse hair over the head, ample subcutaneous tissue
over the arms and legs, and severe strokes beginning at age 4) that
may subtly distinguish this phenotype from classical HGPS.
The two UPD cases present an interesting dilemma: if the LMNA
gene sequence is normal in both cases, why do they have HGPS? The
possibility of imprinting must be considered; however, previous
cases of both paternal and maternal complete isodisomy of chromo-
some 1 do not support the presence of any imprinted loci on this
chromosome15,16. In the case where DNA samples were available
from the mother and sibling (Fig. 1a), we can conclude that this
phenomenon resulted in a chromosome that has partly paternal and
partly maternal alleles. This must have arisen by a post-fertilization
event, probably a mitotic crossover between homologues. We
postulate that these cases actually represent ‘somatic rescue’ events
of the premature senescence phenotype of HGPS. Under this
hypothesis, the individuals from whom these fibroblasts were
derived originally harboured typical codon 608 HGPS mutations
in LMNA. Perhaps as an in vivo event, or perhaps as an in vitro event
in the fibroblast culture, a mitotic crossover occurred, generating a
cell with segmental UPD that had duplicated the wild-type allele of
LMNA and lost the HGPS mutation. Such a cell would probably
then have a growth advantage over its neighbours. Proof of this
hypothesis would require access to multiple tissues of the deceased
UPD patients, which unfortunately are not available.
We also did not identify any mutation in the LMNA gene in the
patient with the 6-Mb deletion (Fig. 1b). We believe that this might
also be due to a somatic rescue event— specifically, we hypothesize
that this patient was originally heterozygous for a codon 608 LMNA
mutation, but in this instance the ‘rescue’ involved an internal
deletion of 6 Mb containing the mutant allele, associated with a
more complex mosaic rearrangement of chromosome 1. A recent
study reported on a case of classical HGPS in which an apparent
interstitial deletion of chromosome 1q23 was seen17. We obtained
cells and DNA from this patient, and to our surprise the typical
heterozygous G608G mutation is present (data not shown).
Furthermore, we have not been able to confirm the presence of an
interstitial deletion by high-resolution chromosome banding or by
FISH with BACs spanning the 1q23–1q24 region. This may be
another example of somatic rescue, involving an interstitial deletion
in the clone of cells analysed in the original report, but not present in
other samples from the same patient.
Extensive prior study of the biochemical function of lamin A
suggests a possible mechanism for disease causation. Lamin A is
normally synthesized as a precursor molecule (prelamin A). At the C
terminus is a CAAX-box motif that is subject to farnesylation. After
that, an internal proteolytic cleavage occurs, removing the last 18
coding amino acids18–20, to generate mature lamin A. We predict
that the codon 11 HGPS mutations and consequent abnormal
splicing would produce a prelamin A that still retains the CAAX
box, but is missing the site for endoproteolytic cleavage. There is
also evidence that cell-cycle-dependent phosphorylation of lamin A
is important for its normal function, and at least one site for
phosphorylation (Ser 625) is deleted in the abnormal HGPS
Figure 2 Point mutations in exon 11 of LMNA cause HGPS. a, Sequence traces from a
normal control and two HGPS patients. b, Hypothesis for activation of a cryptic splice
donor site in exon 11. c, Demonstration of the abnormal splice product using RT–PCR,
showing an abnormal product of 489 bp in the two HGPS probands due to activation of the
cryptic splice site. Alternative lanes to the right lack reverse transcriptase. d, Western blot
using a monoclonal antibody against lamin A/C. Lanes 1, 5, 8 and 9 are from AG03506,
AG03344, AG11498 and AG01972; they all carry G608G(GGC . GGT). Lane 4 is from
AG10801, carrying G608S(GGC . AGC); lanes 2 and 3 are from parents of AG03506;
lanes 6 and 7 are from father of AG03259 and mother of AG06917, respectively.
Lanes 1–5 are from lymphoblastoid cell lines; lanes 6–9 are from fibroblasts. A protein
sample from HeLa cells is in lane 10.
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protein21. As lamin A forms a multiprotein complex within the
inner nuclear membrane, this incompletely processed prelamin A
might well act as a dominant negative.
Notably, defective prelamin A processing has recently been
identified in a mouse knockout of the Zmpste24 metalloprotei-
nase22,23. Zmpste24 is believed to be involved in proteolytic proces-
sing of prelamin A, and may represent the actual endoprotease. The
homozygote knockout of Zmpste24 has a phenotype resembling the
clinical features observed in HGPS patients, including growth
retardation, premature death (20 weeks) from cardiac dysfunction,
and alopecia. However, additional features such as pronounced
osteoporosis are also present23. Immunofluorescence experiments
on cells from these animals show elongated and irregular nuclei with
herniation of the nuclear membrane. A mouse knockout of the
Lmna gene has also been reported previously24, showing severe
postnatal growth retardation, muscular dystrophy and similar
nuclear abnormalities.
To pursue the possibility of structural nuclear membrane
abnormalities in HGPS, immunofluorescence studies with two
different monoclonal antibodies against lamin A/C were performed
on primary fibroblasts from five classical HGPS cases with the
common G608G mutation, as well as unaffected parents. Repre-
sentative data from an affected patient (AG11498) and an unaf-
fected parent (AG06299) are shown in Fig. 3. In 48% of the HGPS
cells we noted an irregular shape of the nuclear envelope (Fig. 3e–h).
Cells from the unaffected control (Fig. 3a–d) showed significantly
fewer cells of this phenotype (,6%). To be certain that this result
was not an artefact of secondary differences in the status of the
HGPS and control fibroblast cultures, cells originating from the
same flasks as the cells used for the immunofluorescence studies
Table 1 LMNA mutations in samples from classical HGPS
Codon 608 nucleotide sequence
Sample ID (classical HGPS) Codon 608 nucleotide sequence Mutation Comment Mother Father Sibling(s)
...................................................................................................................................................................................................................................................................................................................................................................
AG01972 GGC/T G608G – NA NA NA
AG06297 GGC/T G608G – NA NA NA
AG11498 GGC/T G608G – NA NA NA
AG11513 GGC/T G608G – NA NA NA
AG03506 GGC/T G608G – Normal Normal Normal
AG03344 GGC/T G608G – Normal Normal Normal
AG03259 GGC/T G608G – Normal Normal Normal
AG06917 GGC/T G608G – Normal Normal NA
AG10579 GGC/T G608G – NA NA NA
AG10587 GGC/T G608G – Normal NA Normal
HGADFN001 GGC/T G608G – NA NA NA
HGADFN003 GGC/T G608G – NA NA NA
HGALBV009 GGC/T G608G – Normal Normal NA
HGALBV011 GGC/T G608G – Normal Normal NA
HGALBV057 GGC/T G608G – Normal Normal NA
HGADFN008 GGC/T G608G – NA NA NA
HGADFN014 GGC/T G608G – NA NA NA
HGALBV071 GGC/T G608G – NA NA NA
AG10801 A/GGC G608S – Normal Normal NA
AG10578 GGC – UPD Normal NA Normal
HGADFN005 GGC – UPD NA NA NA
C8803 GGC – Deletion Normal Normal NA
AG10677 GGC E145K – Normal* Normal* NA
...................................................................................................................................................................................................................................................................................................................................................................
Additional sequence variants, presumed to be polymorphisms, were identified in exon 3 (L240L(CTG . CTA)), intron 4 (IVS4 þ 61C . T), exon 5 (A287A(GCT . GCC)), exon 7 (D446D(GAT . GAC)),
intron 8 (IVS8 2 41C . T) and exon 10 (H566H(CAC . CAT)). The variants in exons 5, 7 and 10 have been reported previously4,28. NA, not available.
*Normal at codon 145.
Figure 3 Immunofluorescence on primary dermal fibroblasts from an unaffected mother
and a child with classical HGPS, using antibody JOL2 against lamin A/C. Identical results
were obtained with antibody XB10 (data not shown). a–d, Results from an unaffected
mother, AG06299. e–h, Results from a classical HGPS patient, AG11498. a, e, Antibody
against lamin A/C. b, f, DAPI staining showing location of the nuclei. c, g, Antibody
staining mitochondria, showing distribution of the cytosol. d, h, Merged image of a–c (d)
and e–g (h).
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were monitored for differences in cell cycle (by fluorescent-activated
cell analysis) and degree of apoptosis. No significant differences
between the cells derived from the classical HGPS patients and the
unaffected parents were noted.
HGPS can now be added to the long list of human genetic
disorders shown to be due to mutations in the LMNA gene3,4. As
most cases of HGPS appear to have a de novo mutation in the
same codon, molecular diagnostics should be almost immediately
feasible. This will be particularly useful in making the diagnosis in a
young child before the full clinical phenotype has appeared.
Molecular diagnostic methods may also provide reassurance in
the prenatal arena, where the possibility of parental somatic
mosaicism and recurrence of disease in future pregnancies can
now be addressed. Finally, the discovery of the molecular basis of
HGPS suggests a possible role for LMNA in aspects of the normal
ageing process. It will be important to look for common variants in
this gene that might show association with exceptional longevity,
and perhaps also to explore whether somatic mutations in LMNA,
accumulated over a lifetime, have some role in senescence. A
Methods
Subjects and DNA/RNA preparation
This study was approved through the NIH Human Subjects review process. Primary
dermal fibroblast cell cultures and EBV-transformed lymphoblastoid cell lines from
individuals diagnosed as classical HGPS, and their first-degree relatives (when available),
were obtained from the Aging Repository of the Coriell Cell Repository (CCR), and the
Progeria Research Foundation Cell and Tissue Bank. DNA was prepared using the
Puregene DNA isolation kit (Gentra Systems). The genome scan for homozygosity
included samples derived from 12 classical HGPS patients (samples AG01972, AG03259,
AG03344, AG03506, AG06297, AG06917, AG10578, AG10579, AG10587, AG10801,
AG11498 and AG11513) and 16 unaffected first-degree relatives (samples AG03258,
AG03260, AG03262, AG03263, AG03343, AG03342, AG03345, AG03346, AG03504,
AG03505, AGO3507, AGO3508, AG06298, AG06299, AG10585 and AG10588). Additional
samples used in this study were samples from classical HGPS (samples AG10677,
HGADFN001, HGADFN003, HGALBV009, HGALBV011, HGALBV057, HGADFN005,
HGADFN008, HGADFN014, HGALBV071 and C8803 (also known as AG10548 in the
CCR)) and samples derived from their unaffected first-degree relatives (samples
HGMLBV010, HGFLBV021, HGMLBV023, HGFLBV031, HGMLBV066, HGFLBV067,
HGMLBV013, HGFLBV050, HGMLBV058, HGSLBV059, HGMLBV078 HGFLBV079,
HGFLBV082 and HGMLBV081). Total RNA was extracted from cells with TRIzol reagent
(Invitrogen).
Genotyping
The whole-genome scan included 403 highly polymorphic microsatellite markers with an
average spacing of 9.2 cM and average heterozygosity of about 0.8 (E. Gillanders, M. Jones,
D. Freas-Lutz, R. Sood and J. Trent, manuscript in preparation). Pedigree checking was
performed using PedCheck (J. O’Connell, http://watson.hgen.pitt.edu/register/docs/
pedcheck.html) and any identified genotype errors were removed. We carried out
homozygosity mapping assuming various degrees of inbreeding for the HGPS cases25.
Additional microsatellite repeats on chromosome 1q were identified using the Sputnik
program (C. Abajian, http://rast.abajian.com/sputnik/) (see Supplementary Table 1) and
were used to further investigate the UPD cases and the paternal deletion region in C8803.
Microsatellite markers were analysed using a 3100 genetic analyser (PE Biosystems).
Genotypes were analysed using GeneScan 3.7 and Genotyper 2.5 Software (PE
Biosystems).
FISH analysis
Single- and two-colour FISH was performed on metaphases from sample C8803 following
previously published procedures26, using a subset of BACs in the region of the paternal
deletion. BACs used as probes for the FISH were RP1-140J1, RP1-148L21, RP1-178F15,
RP11-137P24, RP11-66D17, RP11-110J1, RP11-91G5, RP11-120D12, RP11-101J8,
RP11-81N17, RP11-144L1, RP11-317F9, RP11-452O22 and RP11-137M19.
Mutation analysis of LMNA
Direct sequencing of LMNA was performed primarily using previously described primer
sequences for the LMNA exons 1–12 (ref. 27). Sequencing reactions were performed at
quarter strength reaction volumes with the Big Dye Terminator chemistry kit (Applied
Biosystems), and electrophoresed on an ABI 3700 DNA Analyser (Applied Biosystems).
Multiple sequence alignment was performed with Sequencher (Genecodes Inc.). Attempts
were made to sequence all PCR products in both directions, but approximately 7% of
exons failed to yield readable sequence.
RT–PCR on exon 11
For all RNA samples, 20 mg of total RNA was treated with RQ1 RNase-Free DNase
according to manufacturers recommendations (Promega). A total of 800 ng of DNase-
treated total RNA was used for first-strand complementary DNA synthesis with random
hexamers (Superscript, Invitrogen). Control samples without reverse transcriptase were
processed at the same time for each sample. PCR primers for the lamin A/C gene were
designed in exon 7/8 and exon 12. Primer sequences were 5 0 -GCAACAAGTCCAATGA
GGACCA-3 0 and 5 0 -GTCCCAGATTACATGATGC-3 0 . PCR fragments were gel-purified
or cloned (TOPO TA-cloning kit, Invitrogen) and sequenced. PCR with GAPDH-specific
primers was performed on all samples as control.
Western analysis
Whole cells (1 £ 106) were collected and washed twice in PBS, the pellets were
resuspended in RIPA buffer and included a cocktail of proteinase inhibitors (Roche). A
total of 20 mg of protein was loaded and electrophoresed on an 8% Tris-Glycine mini gel
(Invitrogen). Primary monoclonal lamin A/C antibody was clone JOL2 (Chemicon
International).
Immunofluorescence
Cultivated fibroblasts were fixed (3.2% paraformaldehyde), permeabilized (1% NP-40),
blocked (0.1% Brij58 and 5% serum) and labelled for lamin A/C (monoclonal antibodies
JOL2, Chemicon International, and clone XB10, CRP Inc.) mitochondria (HMS-0100,
Immunovision Inc.) and DNA (using 4,6-diamidine-2-phenylindole (DAPI)
dihydrochloride mixed in at 1 mg ml21 with the second antibody). Analysis was done by
confocal microscopy using a Biorad 1024 and Leica SP2 systems.
Cell cycle and apoptosis
Cells were collected and washed in PBS one day after the immunofluorescence
experiments. Duplicate experiments were performed on each cell culture. A total of 5 £ 105
cells were resuspended in 0.5 ml of NuCycl propidium iodide (NuCycl PI kit, Exalpha) and
processed as recommended by the manufacturer. The total DNA content was measured by
DNA flow cytometry. Cells were also assayed for viability using annexin V-fluorescein
isothiocyanate and propidium iodide according to standardized procedures (BD
Biosciences).
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Numerous studies of the underlying causes of ageing have been
attempted by examining diseases associated with premature
ageing, such as Werner’s syndrome and Hutchinson–Gilford
progeria syndrome (HGPS). HGPS is a rare genetic disorder
resulting in phenotypes suggestive of accelerated ageing, includ-
ing shortened stature, craniofacial disproportion, very thin skin,
alopecia and osteoporosis, with death in the early teens predomi-
nantly due to atherosclerosis1. However, recent reports suggest
that developmental abnormalities may also be important in
HGPS1,2. Here we describe the derivation of mice carrying an
autosomal recessive mutation in the lamin A gene (Lmna)
encoding A-type lamins, major components of the nuclear
lamina3. Homozygous mice display defects consistent with
HGPS, including a marked reduction in growth rate and death
by 4 weeks of age. Pathologies in bone, muscle and skin are also
consistent with progeria. The Lmna mutation resulted in nuclear
morphology defects and decreased lifespan of homozygous fibro-
blasts, suggesting premature cell death. Here we present a mouse
model for progeria that may elucidate mechanisms of ageing and
development in certain tissue types, especially those developing
from the mesenchymal cell lineage.
The Lmna gene encodes the A-type lamins, intermediate filament
family members that make up the nuclear lamina, a fibrous network
underlying the nuclear envelope3. Alternative splicing of Lmna
transcripts gives rise to four proteins: two major products called
lamin A and lamin C, and two minor products, laminAD10 and
lamin C2, the latter being specific to the testis. The A-type lamins
interact with B-type lamins, which are encoded by the Lmnb1 and
Lmnb2 genes, in a largely uncharacterized assembly process to form
the nuclear lamina. The A-type lamins are developmentally regu-
lated, whereas at least one B-type lamin is expressed in every cell
type at all developmental stages. Embryonic stem cells, cells of the
early embryo and haematopoietic stem cells do not express Lmna;
however, derivatives of these cells do express Lmna during develop-
ment, suggesting a role for Lmna in terminal differentiation4. In
addition to controlling interphase nuclear morphology, the nuclear
lamina also functions in selective retention of proteins in the inner
nuclear membrane, chromatin organization, DNA replication and
gene expression5,6. A role for A-type lamins in regulating gene
expression is further supported by interactions with a growing
number of transcription factors, for example, Rb7 and GCL
indirectly through emerin8.
The indispensable role of lamins in these diverse and funda-
mental processes may account for their association with a growing
list of human diseases. Laminopathies can be divided loosely into
two categories: those affecting striated muscle and those with
phenotypes affecting adipose tissue and bone. Diseases of striated
muscle caused by mutations in the Lmna gene are the autosomal
dominant form of Emery–Dreifuss muscular dystrophy
(AD-EDMD), limb girdle muscular dystrophy 1B (LGMD1B) and
dilated cardiomyopathy with conduction system disease
(DCM–CD). A single recessive mutation in Lmna has also been
implicated in Charcot–Marie–Tooth syndrome type 2B1
(CMT2B1), a peripheral neuropathy with muscle weakness and
wasting. Dunnigan’s familial partial lipodystrophy (FPLD) and
mandibuloacral dysplasia (MAD), disorders primarily resulting in
loss and redistribution of white adipose tissue, are also associated
with mutations in Lmna. Hyperlipidaemia, insulin resistance and
diabetes are common in FPLD and MAD patients, and bone defects
in MAD patients include craniofacial abnormalities, osteolysis of
terminal digits and hypoplasia of clavicles9. Many clinical obser-
vations of MAD patients are also seen in progeria patients10,
suggesting that the two disorders may be allelic. Although we do
not understand why mutations in Lmna cause such a wide array of
phenotypes, the continued discovery of phenotypic overlap between
some of these diseases indicates that they may represent a spectrum of
related disorders rather than separate diseases. The present descrip-
tion of progeroid symptoms associated with LmnaL530P/L530P mutant
Figure 1 Lmna L530P/L530P homozygous mice exhibit severely retarded growth and die
early. a, The smaller Lmna L530P/L530P mouse weighed 5.37 g; the littermate (21.88 g)
was wild type. b, Mutants failed to thrive, showing marked growth reduction as early as 4
days after birth. Mice were weighed every 2–3 days for 58 days. n ¼ 8 mutant (Hom,
red), 10 wild-type (WT, blue) and 14 heterozygotes (Het, green) mice. c, Heterozygotes
(green) can live as long as wild-type littermates (blue). Mutants (n ¼ 25, red) died by 38
days. d, In 50% of mutant mice, we observed abnormal dentition in the lower jaw. A
heterozygous littermate is on the left.
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